Drug intelligence / Profile preview

[18F]TRACK

Development stage
Preclinical
Lead developer
Universitat Heidelberg
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals, Small Molecules
Administration
Intravenous
01

Overview

[18F]TRACK is a fluorine-18-labeled small molecule radiopharmaceutical designed as a positron emission tomography (PET) imaging tracer for the in vivo quantification of tropomyosin receptor kinases (Trk) in the brain. Developed as an optimized derivative of the carbon-11-labeled tracer [11C]-(R)-IPMICF16, [18F]TRACK exhibits high selectivity and affinity for TrkB and TrkC receptors, with significantly reduced P-glycoprotein (P-gp) efflux liability and improved brain kinetics. The tracer is primarily utilized in clinical research to investigate alterations in Trk receptor density associated with neurodegenerative and psychiatric disorders, such as Alzheimer's disease, and to evaluate target engagement of novel Trk-targeted therapeutics.

Other names
18F-TRACK[18F]-(R)-TRACK[18F]-TRACK[18F]TRACK
02

Targets

NTRK2 (Tropomyosin-related kinase receptor type B)NTRK3 (Tropomyosin receptor kinase C)

Beyond the preview

Go deeper on [18F]TRACK.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [18F]TRACK.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call